Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication
Part of paid clinical trials in State College, Pennsylvania.
- Sponsor
- Penn State University
- Study ID
- NCT06843512
- Status
- Recruiting
Conditions
- Food Selection
- Weight Loss
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- GLP-1 Medication Initiation — OTHEROne visit before starting GLP-1 medication and one visit 3 months after. No other changes administered between visits.
Study Details
In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences in their relationship and reaction to food and in their food selection prior to or within the first two weeks of taking GLP-1 medication to after three months on the medication. The researchers of this study believe that an understanding of such changes can inform questions seeking to ensure maintenance of appropriate nutrient balance within individuals on weight loss medications.
Key Dates
- Start date
- Jul 15, 2025
- Status verified
- Sep 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 25 participants (estimated)
Primary Outcome Measure
Change from Baseline in Total Weight of Food Selected in the VR Buffet at 3 Months [ Time Frame: Baseline and 3 months ]
Central Contacts
- Christina M Blackmon425-499-8049
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University | State College | Pennsylvania | 16802 |
Find similar trials in State College, PA
Related Studies
- Increasing Food Literacy in Preschoolers to Reduce Obesity RiskRecruiting · Penn State University · University Park, Pennsylvania
- Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss TreatmentPHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Phoenix, Arizona
- Bariatric Embolization of Arteries for the Treatment of Nonalcoholic SteatohepatitisNot Yet Recruiting · Keith Pereira, MD: · St Louis, Missouri
- Dyad Plus Effectiveness/FeasibilityRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina